Format

Send to

Choose Destination
See comment in PubMed Commons below
Trends Biotechnol. 2009 Jul;27(7):423-33. doi: 10.1016/j.tibtech.2009.04.002. Epub 2009 Jun 6.

Production of self-assembling biomaterials for tissue engineering.

Author information

1
Astbury Centre for Structural Molecular Biology, University of Leeds, Leeds, LS2 9JT, UK. bmbsky@leeds.ac.uk

Abstract

Self-assembling peptide-based biomaterials are being developed for use as 3D tissue engineering scaffolds and for therapeutic drug-release applications. Chemical synthesis provides custom-made peptides in small quantities, but production approaches based upon transgenic organisms might be more cost-effective for large-scale peptide production. Long lead times for developing appropriate animal clones or plant lines and potential negative public opinion are obstacles to these routes. Microbes, particularly safe organisms used in the food industry, offer a more rapid route to the large-scale production of recombinant self-assembling biomaterials. In this review, recent advances and challenges in the recombinant production of collagen, elastin and de novo designed self-assembling peptides are discussed.

PMID:
19497631
PMCID:
PMC2828541
DOI:
10.1016/j.tibtech.2009.04.002
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Elsevier Science Icon for PubMed Central
    Loading ...
    Support Center